Bristol-Myers Squibb Company Stands by $60 Per Share ImClone Systems Incorporated Offer

September 12, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

NEW YORK, Sept 11 (Reuters) - Bristol-Myers Squibb Co stood by its $60-a-share offer for ImClone Systems Inc, a day after the biotechnology company spurned Bristol's offer and said it had another bid at $70 a share.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions

Bristol Myers Squibb Company